News
Stocktwits on MSN52m
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided
Merck (MRK) announced on Monday that the Canadian regulator, Health Canada, has granted approval for its cancer drug Keytruda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback